Home NDC 0009-5138 Zyvox
Product NDC 0009-5138
11-digit product format 000095138
Labeler code 0009
Product ID 0009-5138_f61349cd-d7b8-4400-b433-01abcdb0cc99
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name linezolid
Dosage form TABLET, FILM COATED
Route ORAL
Labeler Pharmacia & Upjohn Company LLC
Application NDA021130
Marketing category NDA
Marketing start 2015-10-12
Marketing end 2027-02-28
Substance LINEZOLID
Active strength 600 mg/1
Pharmacologic classes Oxazolidinone Antibacterial [EPC], Oxazolidinones [CS]
NDC exclude flag No
Current FDA listing Yes Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 2 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Product NDC Package NDC Code Status Reporting period Archive Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 0009-5138 0009-5138-03 D Discontinued by firm excluded / ndc_excluded.zip d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 0009-5138 0009-5138-03 D Discontinued by firm excluded / ndc_excluded.zip f5e01cc5f278…a2eaf40c39c3…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N021130-001 ZYVOX LINEZOLID 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 2000-04-18 N021130-002 ZYVOX LINEZOLID 600MG TABLET / ORAL RLD 2000-04-18
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 3 · 82 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N021130-001 ZYVOX 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 2000-04-18 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N021130-002 ZYVOX 600MG TABLET / ORAL RLD 2000-04-18 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021130-001 ZYVOX 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 2000-04-18 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021130-002 ZYVOX 600MG TABLET / ORAL RLD 2000-04-18 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N021130-001 ZYVOX 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 2000-04-18 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N021130-002 ZYVOX 600MG TABLET / ORAL AB RLD, RS 2000-04-18 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N021130-001 ZYVOX 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 2000-04-18 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N021130-002 ZYVOX 600MG TABLET / ORAL AB RLD, RS 2000-04-18 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N021130-001 ZYVOX 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 2000-04-18 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N021130-002 ZYVOX 600MG TABLET / ORAL AB RLD, RS 2000-04-18 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N021130-001 ZYVOX 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 2000-04-18 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N021130-002 ZYVOX 600MG TABLET / ORAL AB RLD, RS 2000-04-18 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N021130-001 ZYVOX 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 2000-04-18 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N021130-002 ZYVOX 600MG TABLET / ORAL AB RLD, RS 2000-04-18 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N021130-001 ZYVOX 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 2000-04-18 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N021130-002 ZYVOX 600MG TABLET / ORAL AB RLD, RS 2000-04-18 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N021130-001 ZYVOX 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 2000-04-18 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N021130-002 ZYVOX 600MG TABLET / ORAL AB RLD, RS 2000-04-18 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N021130-001 ZYVOX 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 2000-04-18 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N021130-002 ZYVOX 600MG TABLET / ORAL AB RLD, RS 2000-04-18 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N021130-001 ZYVOX 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 2000-04-18 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N021130-002 ZYVOX 600MG TABLET / ORAL AB RLD, RS 2000-04-18 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N021130-001 ZYVOX 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 2000-04-18 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N021130-002 ZYVOX 600MG TABLET / ORAL AB RLD, RS 2000-04-18 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N021130-001 ZYVOX 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 2000-04-18 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N021130-002 ZYVOX 600MG TABLET / ORAL AB RLD, RS 2000-04-18 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N021130-001 ZYVOX 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 2000-04-18 8072bd15b7f6…2024-05-31 18:47 UTC 2024-05 N021130-002 ZYVOX 600MG TABLET / ORAL AB RLD, RS 2000-04-18 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N021130-001 ZYVOX 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 2000-04-18 5c6f7cd8ea54…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N021130-002 ZYVOX 600MG TABLET / ORAL AB RLD, RS 2000-04-18 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N021130-001 ZYVOX 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 2000-04-18 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 N021130-002 ZYVOX 600MG TABLET / ORAL AB RLD, RS 2000-04-18 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N021130-001 ZYVOX 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 2000-04-18 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 N021130-002 ZYVOX 600MG TABLET / ORAL AB RLD, RS 2000-04-18 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 N021130-001 ZYVOX 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** TABLET / ORAL RLD 2000-04-18 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N021130-002 ZYVOX 600MG TABLET / ORAL AB RLD, RS 2000-04-18 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 N021130-001 ZYVOX 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 2000-04-18 bb7c543d1eb4…2022-03-09 01:35 UTC 2022-03 N021130-002 ZYVOX 600MG TABLET / ORAL AB RLD, RS 2000-04-18 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 N021130-001 ZYVOX 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** TABLET / ORAL RLD 2000-04-18 782e0a99824c…2021-12-28 21:50 UTC 2021-12 N021130-002 ZYVOX 600MG TABLET / ORAL AB RLD, RS 2000-04-18 782e0a99824c…
Observed Orange Book normalized TE history# Observed Orange Book patent history# Patent history page 1 of 2 · 72 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2019-12-13 00:20 UTC 2019-12 N021130-001 6559305 2021-01-29 Drug substance 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N021130-001 6514529 2021-03-15 Drug product 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N021130-001 6559305*PED 2021-07-29 Pediatric extension 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N021130-001 6514529*PED 2021-09-15 Pediatric extension 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N021130-002 6559305 2021-01-29 Drug substance 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N021130-002 6514529 2021-03-15 Drug product 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N021130-002 6559305*PED 2021-07-29 Pediatric extension 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N021130-002 6514529*PED 2021-09-15 Pediatric extension 74a2ff9319b5…2021-12-28 21:50 UTC 2021-12 N021130-001 6559305 2021-01-29 Drug substance 782e0a99824c…2021-12-28 21:50 UTC 2021-12 N021130-001 6514529 2021-03-15 Drug product 782e0a99824c…2021-12-28 21:50 UTC 2021-12 N021130-001 6559305*PED 2021-07-29 Pediatric extension 782e0a99824c…2021-12-28 21:50 UTC 2021-12 N021130-001 6514529*PED 2021-09-15 Pediatric extension 782e0a99824c…2021-12-28 21:50 UTC 2021-12 N021130-002 6559305 2021-01-29 Drug substance 782e0a99824c…2021-12-28 21:50 UTC 2021-12 N021130-002 6514529 2021-03-15 Drug product 782e0a99824c…2021-12-28 21:50 UTC 2021-12 N021130-002 6559305*PED 2021-07-29 Pediatric extension 782e0a99824c…2021-12-28 21:50 UTC 2021-12 N021130-002 6514529*PED 2021-09-15 Pediatric extension 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N021130-001 6559305 2021-01-29 Drug substance 87673890dc5c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N021130-001 6514529 2021-03-15 Drug product 87673890dc5c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N021130-001 6559305*PED 2021-07-29 Pediatric extension 87673890dc5c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N021130-001 6514529*PED 2021-09-15 Pediatric extension 87673890dc5c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N021130-002 6559305 2021-01-29 Drug substance 87673890dc5c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N021130-002 6514529 2021-03-15 Drug product 87673890dc5c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N021130-002 6559305*PED 2021-07-29 Pediatric extension 87673890dc5c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N021130-002 6514529*PED 2021-09-15 Pediatric extension 87673890dc5c…2021-03-12 10:30 UTC 2021-03 N021130-001 6559305 2021-01-29 Drug substance 5aa47cf7b7d7…2021-03-12 10:30 UTC 2021-03 N021130-001 6514529 2021-03-15 Drug product 5aa47cf7b7d7…2021-03-12 10:30 UTC 2021-03 N021130-001 6559305*PED 2021-07-29 Pediatric extension 5aa47cf7b7d7…2021-03-12 10:30 UTC 2021-03 N021130-001 6514529*PED 2021-09-15 Pediatric extension 5aa47cf7b7d7…2021-03-12 10:30 UTC 2021-03 N021130-002 6559305 2021-01-29 Drug substance 5aa47cf7b7d7…2021-03-12 10:30 UTC 2021-03 N021130-002 6514529 2021-03-15 Drug product 5aa47cf7b7d7…2021-03-12 10:30 UTC 2021-03 N021130-002 6559305*PED 2021-07-29 Pediatric extension 5aa47cf7b7d7…2021-03-12 10:30 UTC 2021-03 N021130-002 6514529*PED 2021-09-15 Pediatric extension 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 N021130-001 6559305 2021-01-29 Drug substance 8869cabd3fbd…2020-12-22 03:56 UTC 2020-12 N021130-001 6514529 2021-03-15 Drug product 8869cabd3fbd…2020-12-22 03:56 UTC 2020-12 N021130-001 6559305*PED 2021-07-29 Pediatric extension 8869cabd3fbd…2020-12-22 03:56 UTC 2020-12 N021130-001 6514529*PED 2021-09-15 Pediatric extension 8869cabd3fbd…2020-12-22 03:56 UTC 2020-12 N021130-002 6559305 2021-01-29 Drug substance 8869cabd3fbd…2020-12-22 03:56 UTC 2020-12 N021130-002 6514529 2021-03-15 Drug product 8869cabd3fbd…2020-12-22 03:56 UTC 2020-12 N021130-002 6559305*PED 2021-07-29 Pediatric extension 8869cabd3fbd…2020-12-22 03:56 UTC 2020-12 N021130-002 6514529*PED 2021-09-15 Pediatric extension 8869cabd3fbd…
Additional Listing Data#
Finished product Yes
Brand name base Zyvox Active Ingredients# Ingredient, Strength table Ingredient Strength LINEZOLID 600 mg/1
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination ISQ9I6J12J Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 8 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 262091 Internal RxNorm lookup 311345 Internal RxNorm lookup 311347 Internal RxNorm lookup 581614 Internal RxNorm lookup 1662278 Internal RxNorm lookup 1662280 Internal RxNorm lookup 1662285 Internal RxNorm lookup 1662286 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 0009-5138-02 Zyvox 20 in 1 BOTTLE TABLET, FILM COATED 20 69 0009-5138-03 Zyvox 1 in 1 BLISTER PACK TABLET, FILM COATED 1 69 0009-5138-03 Zyvox 30 in 1 BOX, UNIT-DOSE TABLET, FILM COATED 30 69
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded LINEZOLID ACTIVE INGREDIENT ISQ9I6J12J ZYVOX (LINEZOLID) INJECTION, SOLUTION ZYVOX (LINEZOLID) TABLET, FILM COATED ZYVOX (LINEZOLID) SUSPENSION [PHARMACIA AND UPJOHN COMPANY] 33 LINEZOLID ACTIVE MOIETY ISQ9I6J12J ZYVOX (LINEZOLID) INJECTION, SOLUTION ZYVOX (LINEZOLID) TABLET, FILM COATED ZYVOX (LINEZOLID) SUSPENSION [PHARMACIA AND UPJOHN COMPANY] 33 ASPARTAME INACTIVE INGREDIENT Z0H242BBR1 ZYVOX (LINEZOLID) INJECTION, SOLUTION ZYVOX (LINEZOLID) TABLET, FILM COATED ZYVOX (LINEZOLID) SUSPENSION [PHARMACIA AND UPJOHN COMPANY] 33 CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM INACTIVE INGREDIENT K679OBS311 ZYVOX (LINEZOLID) INJECTION, SOLUTION ZYVOX (LINEZOLID) TABLET, FILM COATED ZYVOX (LINEZOLID) SUSPENSION [PHARMACIA AND UPJOHN COMPANY] 33 CARNAUBA WAX INACTIVE INGREDIENT R12CBM0EIZ ZYVOX (LINEZOLID) INJECTION, SOLUTION ZYVOX (LINEZOLID) TABLET, FILM COATED ZYVOX (LINEZOLID) SUSPENSION [PHARMACIA AND UPJOHN COMPANY] 33 CELLULOSE, MICROCRYSTALLINE INACTIVE INGREDIENT OP1R32D61U ZYVOX (LINEZOLID) INJECTION, SOLUTION ZYVOX (LINEZOLID) TABLET, FILM COATED ZYVOX (LINEZOLID) SUSPENSION [PHARMACIA AND UPJOHN COMPANY] 33 CITRIC ACID MONOHYDRATE INACTIVE INGREDIENT 2968PHW8QP ZYVOX (LINEZOLID) INJECTION, SOLUTION ZYVOX (LINEZOLID) TABLET, FILM COATED ZYVOX (LINEZOLID) SUSPENSION [PHARMACIA AND UPJOHN COMPANY] 33 DEXTROSE INACTIVE INGREDIENT IY9XDZ35W2 ZYVOX (LINEZOLID) INJECTION, SOLUTION ZYVOX (LINEZOLID) TABLET, FILM COATED ZYVOX (LINEZOLID) SUSPENSION [PHARMACIA AND UPJOHN COMPANY] 33 HYDROXYPROPYL CELLULOSE (TYPE H) INACTIVE INGREDIENT RFW2ET671P ZYVOX (LINEZOLID) INJECTION, SOLUTION ZYVOX (LINEZOLID) TABLET, FILM COATED ZYVOX (LINEZOLID) SUSPENSION [PHARMACIA AND UPJOHN COMPANY] 33 HYPROMELLOSES INACTIVE INGREDIENT 3NXW29V3WO ZYVOX (LINEZOLID) INJECTION, SOLUTION ZYVOX (LINEZOLID) TABLET, FILM COATED ZYVOX (LINEZOLID) SUSPENSION [PHARMACIA AND UPJOHN COMPANY] 33 MAGNESIUM STEARATE INACTIVE INGREDIENT 70097M6I30 ZYVOX (LINEZOLID) INJECTION, SOLUTION ZYVOX (LINEZOLID) TABLET, FILM COATED ZYVOX (LINEZOLID) SUSPENSION [PHARMACIA AND UPJOHN COMPANY] 33 MANNITOL INACTIVE INGREDIENT 3OWL53L36A ZYVOX (LINEZOLID) INJECTION, SOLUTION ZYVOX (LINEZOLID) TABLET, FILM COATED ZYVOX (LINEZOLID) SUSPENSION [PHARMACIA AND UPJOHN COMPANY] 33 POLYETHYLENE GLYCOLS INACTIVE INGREDIENT 3WJQ0SDW1A ZYVOX (LINEZOLID) INJECTION, SOLUTION ZYVOX (LINEZOLID) TABLET, FILM COATED ZYVOX (LINEZOLID) SUSPENSION [PHARMACIA AND UPJOHN COMPANY] 33 SILICON DIOXIDE INACTIVE INGREDIENT ETJ7Z6XBU4 ZYVOX (LINEZOLID) INJECTION, SOLUTION ZYVOX (LINEZOLID) TABLET, FILM COATED ZYVOX (LINEZOLID) SUSPENSION [PHARMACIA AND UPJOHN COMPANY] 33 SODIUM BENZOATE INACTIVE INGREDIENT OJ245FE5EU ZYVOX (LINEZOLID) INJECTION, SOLUTION ZYVOX (LINEZOLID) TABLET, FILM COATED ZYVOX (LINEZOLID) SUSPENSION [PHARMACIA AND UPJOHN COMPANY] 33 SODIUM CHLORIDE INACTIVE INGREDIENT 451W47IQ8X ZYVOX (LINEZOLID) INJECTION, SOLUTION ZYVOX (LINEZOLID) TABLET, FILM COATED ZYVOX (LINEZOLID) SUSPENSION [PHARMACIA AND UPJOHN COMPANY] 33 SODIUM CITRATE INACTIVE INGREDIENT 1Q73Q2JULR ZYVOX (LINEZOLID) INJECTION, SOLUTION ZYVOX (LINEZOLID) TABLET, FILM COATED ZYVOX (LINEZOLID) SUSPENSION [PHARMACIA AND UPJOHN COMPANY] 33 STARCH, CORN INACTIVE INGREDIENT O8232NY3SJ ZYVOX (LINEZOLID) INJECTION, SOLUTION ZYVOX (LINEZOLID) TABLET, FILM COATED ZYVOX (LINEZOLID) SUSPENSION [PHARMACIA AND UPJOHN COMPANY] 33 SUCROSE INACTIVE INGREDIENT C151H8M554 ZYVOX (LINEZOLID) INJECTION, SOLUTION ZYVOX (LINEZOLID) TABLET, FILM COATED ZYVOX (LINEZOLID) SUSPENSION [PHARMACIA AND UPJOHN COMPANY] 33 TITANIUM DIOXIDE INACTIVE INGREDIENT 15FIX9V2JP ZYVOX (LINEZOLID) INJECTION, SOLUTION ZYVOX (LINEZOLID) TABLET, FILM COATED ZYVOX (LINEZOLID) SUSPENSION [PHARMACIA AND UPJOHN COMPANY] 33 XANTHAN GUM INACTIVE INGREDIENT TTV12P4NEE ZYVOX (LINEZOLID) INJECTION, SOLUTION ZYVOX (LINEZOLID) TABLET, FILM COATED ZYVOX (LINEZOLID) SUSPENSION [PHARMACIA AND UPJOHN COMPANY] 33
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 0009-5138 ZYVOX (LINEZOLID) INJECTION, SOLUTION ZYVOX (LINEZOLID) GRANULE, FOR SUSPENSION ZYVOX (LINEZOLID) TABLET, FILM COATED [PHARMACIA & UPJOHN COMPANY LLC] 64 Current NDC, Legacy NDC, 3 package rows 20240726_6e70e63b-bfd5-478d-a8ee-8ba22c9efabd.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 2 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 0009-5138-02 00009513802 20 TABLET, FILM COATED in 1 BOTTLE (0009-5138-02) 2015-10-12 2027-02-28 No No Current 0009-5138-03 00009513803 30 BLISTER PACK in 1 BOX, UNIT-DOSE (0009-5138-03) > 1 TABLET, FILM COATED in 1 BLISTER PACK 30 blister pack 2015-10-12 0000-00-00 No No Current